AI Article Synopsis
- Atrial flutter is a prevalent type of arrhythmia, with an incidence of 88 cases per 100,000 people, and poses similar risks for blood clots as atrial fibrillation.
- Pharmacological treatments are generally ineffective, making catheter ablation, especially of the cavotricuspidal isthmus, a preferred option with a success rate of 90-96% and low rates of recurrence.
- Newer techniques like cryo-ablation are emerging as promising alternatives to traditional radiofrequency ablation with comparable results.
Article Abstract
Atrial flutter is one of the most common supraventricular arrhythmic diseases and occurs with an incidence of 88/100,000. The high risk for thromboembolic events is similar to that for atrial fibrillation and also has the risk for fast conduction to the ventricle. Pharmacological treatment is not significantly effective. Catheter ablation of common atrial flutter offers an alternative with a high quality outcome ranging from 90-96% and a low recurrence rate of 2-6%. Radiofrequency catheter ablation of the cavotricuspidal isthmus is an established treatment for common atrial flutter. Modern techniques like cryo-ablation show nearly the same results and will be an alternative to the RF ablation in the future.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00399-008-0001-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!